Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
AIDS Malignancy Consortium
Pliant Therapeutics, Inc.
Medical College of Wisconsin
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
EvolveImmune United, Inc
Institut du Cancer de Montpellier - Val d'Aurelle
OncoC4, Inc.
National Institutes of Health Clinical Center (CC)
AstraZeneca
Sotio Biotech Inc.
AIDS Malignancy Consortium